Inventor

Ellen Filvaroff

Inventor

San Francisco, CA, US

Overview

2003–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 75 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides21%

A61KPreparations for medical, dental or toiletry purposes18%

C12NMicroorganisms or enzymes14%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture10%

G01NInvestigating or analysing materials by determining their chemical or physical properties9%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%

C07HSugars7%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%

Y02PClimate change mitigation technologies in the production or processing of goods2%

PatentTitleYear

11,096,940Treatment of hepatocellular carcinoma characterized by hepatitis B virus infection2021 10,648,983Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies2020 10,576,085Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith2020 8,790,646'Compositions and methods for modulating vascular development'2014 8,338,132'Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof'2012 8,273,703'IL-17 receptor-like polypeptides and therapeutic uses thereof'2012 8,138,152'Methods of treatment using WISP polypeptides'2012 8,110,548'Method for treating cartilage disorders'2012 8,075,888'Methods of treatment using antibodies to IL-17 homologous polypeptides'2011 8,034,342'Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E'2011 8,012,482'Humanized anti-TGF-beta antibodies'2011 7,947,650'Article of manufacture'2011 7,771,719'Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E'2010 7,749,500'Antibodies to IL-17 polypeptides and therapeutic uses thereof'2010 7,732,567'Methods and compositions for modulating and detecting wisp activity'2010 7,723,488'Monoclonal antibodies to secreted and transmembrane polypeptides'2010 7,700,736'PRO350 antibodies'2010 7,687,460'Methods of treatment using wisp polypeptides'2010 7,619,062'PRO214 polypeptides'2009 7,557,192'Anti-PRO335 antibodies'2009 7,527,791'Humanized anti-TGF-beta antibodies'2009 7,491,797'PRO6308 polypeptide'2009 7,470,771'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2008 7,455,834'Methods and compositions for modulating and detecting WISP activity'2008 7,456,262'Methods and composition for modulating and detecting wisp activity'2008 7,452,975'Anti-PRO7168 antibodies'2008 7,432,345'PRO1475 polypeptide'2008 7,423,017'Method for treating cartilage disorders'2008 7,408,042'Anti-PRO6181 antibodies'2008 7,385,031'PRO6097 polypeptides'2008 7,371,836'PRO526 nucleic acids'2008 7,312,303'Anti-PRO4980 antibodies'2007 7,309,778'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2007 7,307,152'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2007 7,304,126'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2007 7,297,770'PRO6496 polypeptides'2007 7,297,769'PRO698 polypeptides'2007 7,294,693'Pro4428 Polypeptides'2007 7,294,696'PRO7168 polypeptides'2007 7,294,695'PRO10268 polypeptides'2007 7,288,384'Antibodies to polypeptides encoded by a nucleic acid underexpressed in esophageal tumor'2007 7,285,644'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2007 7,279,552'Pro1782 polypeptides'2007 7,268,112'Use of insulin for the treatment of cartilaginous disorders'2007 7,241,865'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2007 7,230,082'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2007 7,217,412'IL-17C related mammalian cytokine polypeptides'2007 7,214,656'PRO792 polypeptides'2007 7,208,308'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2007 7,208,575'PRO531 polypeptides'2007 7,208,312'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2007 7,196,165'PRO363 polypeptides'2007 7,195,760'Anti-pro363 antibodies'2007 7,193,049'PRO862 polypeptides'2007 7,189,563'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2007 7,189,813'PRO1338 polypeptides'2007 7,189,529'PRO792 nucleic acids'2007 7,160,993'Nucleic acids encoding PRO4400 polypeptides'2007 7,115,398'IL-17 homologous polypeptides and therapeutic uses thereof'2006 7,109,305'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2006 7,094,567'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2006 7,081,520'Anti-pro 1570 antibodies'2006 7,074,592'Secreted and transmembrane polypeptides nucleic acid encoding'2006 7,029,874'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2006 7,018,837'Nucleic acids encoding secreted polypeptides that stimulate release of proteoglycans from cartilage'2006 6,974,689'Nucleic acid encoding PRO211 polypeptides'2005 6,936,254'Method of inducing fetal hemoglobin synthesis'2005 6,734,288'Antibodies against a secreted polypeptide that stimulates release of proteoglycans from cartilage'2004 6,723,535'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2004 6,689,747'Use of insulin for the treatment of cartilagenous disorders'2004 6,664,376'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2003 6,642,360'Secreted polypeptides that stimulate release of proteoglycans from cartilage'2003 6,635,468'Secreted and transmembrane polypeptides and nucleic acids encoding the same'2003 6,579,520'IL-17 related mammalian cytokine polypeptides (IL-17E)'2003 6,569,645'IL-17 homologous polypeptides and therapeutic uses thereof'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2014Patents assigned to GENENTECH INC (72)· patent assignee history

2003–2021Based in San Francisco, CA, US· patent location history

2011–2014Patents assigned to FILVAROFF ELLEN (5)· patent assignee history

2011–2012Patents assigned to CHEN JIAN (3)· patent assignee history

2011–2012Patents assigned to GODDARD AUDREY (3)· patent assignee history

2011–2012Patents assigned to LI HANZHONG (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
GENENTECH INC	72	2003–2014
FILVAROFF ELLENself	5	2011–2014
CHEN JIAN	3	2011–2012
GODDARD AUDREY	3	2011–2012
LI HANZHONG	3	2011–2012

Locations

Location	Patents	Span
San Francisco, California, US	75	2003–2021